22.10.2016 | Case Report
Survival after intravenous thrombin prior to cardiopulmonary bypass
verfasst von:
Vance G. Nielsen, Samata R. Paidy, Camron A. Meek, Tiffany K. Thornton, Scott D. Lick
Erschienen in:
International Journal of Legal Medicine
|
Ausgabe 2/2017
Einloggen, um Zugang zu erhalten
Abstract
We present a case of a patient undergoing aortic valve replacement being inadvertently administered 5000 U of bovine thrombin instead of heparin for anticoagulation for cardiopulmonary bypass. The labeling error was made within the operating room pharmacy. The key to survival of this patient was a rapid diagnosis, administration of antithrombin and heparin, and removal of cardiac and great vessel thrombi. It is recommended that point of care anesthesia providers `prepare heparin for cardiopulmonary bypass anticoagulation, as thrombin is not used in anesthetic practice and is not contained within anesthesia cabinet medication drawers.